yasmeen: absolutely true.ne of t challenges we are facing with omicron, some of the existing treatments we have in more abundant supply, are not effective against this variant. two of the three monoclonal antibodies that the u.s. has does not work against omicron, which means officials are having to preserve the one that does work. the other two do not work against omicron. while these antiviral pills are good news, the more medications we have the better. the me ways we have to treat covid better. these are also in limited supply, just authorized by the fda this week. a lot of people who need it will not be able to get it. it will be a limited supply for a few weeks. yamiche: important for people to understand the context of these pills. thank you. ther is not much appetite for people shutting down and being back indoors, especially in the holidays. i want to talk about the science of this. president biden has been promising there will be no more lockdowns. what does that tell you whether that is a scientific